Clinical trials
Completed Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
196 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 10 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 9 |
| 2016 | 17 |
| 2017 | 18 |
| 2018 | 28 |
| 2019 | 29 |
| 2020 | 12 |
| 2021 | 11 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 196 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Bristol-Myers Squibb | 5 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Eli Lilly and Company | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 4 |
| Hoffmann-La Roche | 4 |
| Incyte Corporation | 4 |
| Pfizer | 4 |
| Xencor, Inc. | 4 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 196 |
| Urinary Bladder Neoplasms | 73 |
| Carcinoma, Non-Small-Cell Lung | 40 |
| Melanoma | 28 |
| Carcinoma, Renal Cell | 27 |
| Squamous Cell Carcinoma of Head and Neck | 25 |
| Neoplasm Metastasis | 18 |
| Colorectal Neoplasms | 17 |
| Ureteral Neoplasms | 16 |
| Carcinoma, Hepatocellular | 15 |
Trials
Showing 51 to 75 of 196. Each trial links to its page on Pharma Observatory.
96 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.